Vaccines against myasthenia gravis

Author： Berrih-Aknin Sonia   Fuchs Sara   Souroujon Miriam C  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.5, Iss.7, 2005-07, pp. : 983-995

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic factors and health-related quality of life in ocular myasthenia gravis (OMG)

By Ariatti Alessandra   Stefani Marina   Miceli Pietro   Benuzzi Francesca   Galassi Giuliana  

International Journal of Neuroscience, Vol. 124, Iss. 6, 2014-06 ,pp. : 427-435

Informa Healthcare

Access to resources Recommend Favorite

DNA vaccines against anthrax

By Galloway Darrell R   Baillie Les  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 10, 2004-10 ,pp. : 1661-1667

Informa Healthcare

Access to resources Recommend Favorite

Vaccines against cervical cancer

By Jansen Kathrin U  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 11, 2004-11 ,pp. : 1803-1809

Informa Healthcare

Access to resources Recommend Favorite

Vaccines against meningococcal disease: current and future technologies

By Riddell A.   Buttery J.  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 3, 2001-05 ,pp. : 385-399

Informa Healthcare

Access to resources Recommend Favorite

Plant-derived vaccines against diarrhoeal diseases

By Tacket Carol O  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 5, 2004-05 ,pp. : 719-728

Informa Healthcare

Access to resources Recommend Favorite